Cephalexin Treatment for Cellulitis
For uncomplicated, non-purulent cellulitis in adults without β-lactam allergy, treat with cephalexin 500 mg orally four times daily for 5-7 days. This dosing is supported by the IDSA guidelines and FDA labeling, targeting the most common pathogens (methicillin-sensitive Staphylococcus aureus and β-hemolytic streptococci) 1, 2.
Standard Dosing Regimen
Cephalexin 500 mg orally four times daily (QID) is the recommended dose for adults with cellulitis 1, 2. The FDA label specifies that for skin and soft tissue infections, 500 mg every 12 hours is acceptable for uncomplicated cases, but the IDSA guidelines consistently recommend 500 mg QID for MSSA skin infections 1.
- Duration: 5-7 days for uncomplicated cellulitis 3
- Pediatric dosing: 25-50 mg/kg/day divided into 4 doses 1, 2
Emerging Evidence on Higher Dosing
A 2023 pilot RCT suggests that high-dose cephalexin (1000 mg QID) may reduce treatment failure rates compared to standard dosing (500 mg QID), with treatment failure occurring in only 3.2% vs 12.9% of patients, though this came with more minor adverse effects 4. While promising, this remains preliminary evidence and the standard 500 mg QID remains guideline-recommended until larger trials confirm these findings.
When NOT to Use Cephalexin Alone
Do not use cephalexin monotherapy in these situations:
- Purulent cellulitis or associated abscess: Requires MRSA coverage with agents like trimethoprim-sulfamethoxazole, clindamycin, or doxycycline 1
- Severe infection with SIRS criteria (fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24/min, WBC >12,000 or <4,000): Requires IV antibiotics with MRSA coverage 1
- Failed initial antibiotic treatment: Switch to MRSA-active regimen 1
- High local MRSA prevalence with moderate-severe cellulitis: Consider adding trimethoprim-sulfamethoxazole, though a large RCT showed no significant benefit in the per-protocol analysis 5
Important Caveat on MRSA Coverage
For non-purulent cellulitis, routine MRSA coverage is NOT recommended despite rising community-acquired MRSA rates 6, 3. The pathogen in non-purulent cellulitis remains predominantly β-hemolytic streptococci. However, one retrospective study from Hawaii (high MRSA prevalence area) found trimethoprim-sulfamethoxazole had significantly higher success rates than cephalexin (91% vs 74%) 7. This conflicts with the 2017 multicenter RCT showing no superiority of combination therapy 5. The weight of evidence supports cephalexin monotherapy for typical non-purulent cellulitis, but consider local resistance patterns.
Alternatives for β-Lactam Allergy
For patients with reported penicillin/cephalosporin allergy:
Non-Severe, Delayed-Type Reactions (e.g., rash)
- Cephalexin can still be used if the reaction to penicillin was non-severe and delayed-type, as cross-reactivity is primarily due to side-chain similarities, not the β-lactam ring 8
- Cephalexin has unique side chains that minimize cross-reactivity 9, 10
Immediate-Type or Severe Reactions (urticaria, angioedema, anaphylaxis)
Use non-β-lactam alternatives:
- Clindamycin 300-450 mg QID orally 1
- Doxycycline or minocycline 100 mg twice daily 1
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily (limited efficacy data for streptococcal coverage) 1
Critical pitfall: Avoid using cephalexin in patients with documented immediate hypersensitivity to cephalosporins with similar side chains (cefaclor, cefamandole) 8. However, cephalosporins with dissimilar side chains can be used even in these patients 8.
Severe Infections Requiring IV Therapy
For severe cellulitis with SIRS or systemic toxicity:
- MSSA coverage: Cefazolin 1 g IV every 8 hours or nafcillin/oxacillin 1-2 g IV every 4 hours 1
- MRSA coverage: Vancomycin 30 mg/kg/day IV in 2 divided doses 1
- Penicillin allergy (non-immediate): Cefazolin is safe and preferred 1
- Penicillin allergy (immediate-type): Vancomycin for MRSA or clindamycin 600 mg IV every 8 hours 1
Key Clinical Pearls
- Bilateral cellulitis is rare—consider alternative diagnoses like venous stasis dermatitis 3
- Always perform ultrasound if abscess is suspected—abscesses require incision and drainage, not just antibiotics 3
- Treatment failure occurs in ~20% of cases—if no improvement by 48-72 hours, reassess for abscess, resistant organisms, or alternative diagnosis 4, 6
- Recurrence is common (up to 29%)—address risk factors like lymphedema and dependent edema 3